A Clostridium difficile-fertozések epidemiológiája, betegségterhe és terápiája

Translated title of the contribution: Clostridium difficile infection: epidemiology, disease burden and therapy

László Gulácsi, Adrienne Kertész, Irén Kopcsóné Németh, János Banai, Endre Ludwig, Gyula Prinz, Péter Reményi, Bálint Strbák, Edit Zsoldiné Urbán, Petra Baji, Márta Péntek, Valentin Brodszky

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction:C. difficile causes 25 percent of the antibiotic associated infectious nosocomial diarrhoeas. C. difficile infection is a high-priority problem of public health in each country. The available literature of C. difficile infection's epidemiology and disease burden is limited. Aim: Review of the epidemiology, including seasonality and the risk of recurrences, of the disease burden and of the therapy of C. difficile infection. Method: Review of the international and Hungarian literature in MEDLINE database using PubMed up to and including 20th of March, 2012. Results: The incidence of nosocomial C. difficile associated diarrhoea is 4.1/10 000 patient day. The seasonality of C. difficile infection is unproved. 20 percent of the patients have recurrence after metronidazole or vancomycin treatment, and each recurrence increases the chance of a further one. The cost of C. difficile infection is between 130 and 500 thousand HUF (430 and 1665) in Hungary. Conclusions: The importance of C. difficile infection in public health and the associated disease burden are significant. The available data in Hungary are limited, further studies in epidemiology and health economics are required.

Original languageHungarian
Pages (from-to)1188-1193
Number of pages6
JournalOrvosi Hetilap
Volume154
Issue number30
DOIs
Publication statusPublished - Jul 1 2013

Fingerprint

Clostridium Infections
Clostridium difficile
Epidemiology
Hungary
Therapeutics
Recurrence
Diarrhea
Public Health
Metronidazole
Vancomycin
PubMed
MEDLINE
Economics
Databases
Anti-Bacterial Agents
Costs and Cost Analysis
Incidence
Health

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gulácsi, L., Kertész, A., Kopcsóné Németh, I., Banai, J., Ludwig, E., Prinz, G., ... Brodszky, V. (2013). A Clostridium difficile-fertozések epidemiológiája, betegségterhe és terápiája. Orvosi Hetilap, 154(30), 1188-1193. https://doi.org/10.1556/OH.2013.29674

A Clostridium difficile-fertozések epidemiológiája, betegségterhe és terápiája. / Gulácsi, László; Kertész, Adrienne; Kopcsóné Németh, Irén; Banai, János; Ludwig, Endre; Prinz, Gyula; Reményi, Péter; Strbák, Bálint; Urbán, Edit Zsoldiné; Baji, Petra; Péntek, Márta; Brodszky, Valentin.

In: Orvosi Hetilap, Vol. 154, No. 30, 01.07.2013, p. 1188-1193.

Research output: Contribution to journalArticle

Gulácsi, L, Kertész, A, Kopcsóné Németh, I, Banai, J, Ludwig, E, Prinz, G, Reményi, P, Strbák, B, Urbán, EZ, Baji, P, Péntek, M & Brodszky, V 2013, 'A Clostridium difficile-fertozések epidemiológiája, betegségterhe és terápiája', Orvosi Hetilap, vol. 154, no. 30, pp. 1188-1193. https://doi.org/10.1556/OH.2013.29674
Gulácsi L, Kertész A, Kopcsóné Németh I, Banai J, Ludwig E, Prinz G et al. A Clostridium difficile-fertozések epidemiológiája, betegségterhe és terápiája. Orvosi Hetilap. 2013 Jul 1;154(30):1188-1193. https://doi.org/10.1556/OH.2013.29674
Gulácsi, László ; Kertész, Adrienne ; Kopcsóné Németh, Irén ; Banai, János ; Ludwig, Endre ; Prinz, Gyula ; Reményi, Péter ; Strbák, Bálint ; Urbán, Edit Zsoldiné ; Baji, Petra ; Péntek, Márta ; Brodszky, Valentin. / A Clostridium difficile-fertozések epidemiológiája, betegségterhe és terápiája. In: Orvosi Hetilap. 2013 ; Vol. 154, No. 30. pp. 1188-1193.
@article{02114514fbd749e99bc88b9b5f9918ce,
title = "A Clostridium difficile-fertoz{\'e}sek epidemiol{\'o}gi{\'a}ja, betegs{\'e}gterhe {\'e}s ter{\'a}pi{\'a}ja",
abstract = "Introduction:C. difficile causes 25 percent of the antibiotic associated infectious nosocomial diarrhoeas. C. difficile infection is a high-priority problem of public health in each country. The available literature of C. difficile infection's epidemiology and disease burden is limited. Aim: Review of the epidemiology, including seasonality and the risk of recurrences, of the disease burden and of the therapy of C. difficile infection. Method: Review of the international and Hungarian literature in MEDLINE database using PubMed up to and including 20th of March, 2012. Results: The incidence of nosocomial C. difficile associated diarrhoea is 4.1/10 000 patient day. The seasonality of C. difficile infection is unproved. 20 percent of the patients have recurrence after metronidazole or vancomycin treatment, and each recurrence increases the chance of a further one. The cost of C. difficile infection is between 130 and 500 thousand HUF (430 and 1665) in Hungary. Conclusions: The importance of C. difficile infection in public health and the associated disease burden are significant. The available data in Hungary are limited, further studies in epidemiology and health economics are required.",
keywords = "C. difficile infection, costs, epidemiology, Hungary",
author = "L{\'a}szl{\'o} Gul{\'a}csi and Adrienne Kert{\'e}sz and {Kopcs{\'o}n{\'e} N{\'e}meth}, Ir{\'e}n and J{\'a}nos Banai and Endre Ludwig and Gyula Prinz and P{\'e}ter Rem{\'e}nyi and B{\'a}lint Strb{\'a}k and Urb{\'a}n, {Edit Zsoldin{\'e}} and Petra Baji and M{\'a}rta P{\'e}ntek and Valentin Brodszky",
year = "2013",
month = "7",
day = "1",
doi = "10.1556/OH.2013.29674",
language = "Hungarian",
volume = "154",
pages = "1188--1193",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "30",

}

TY - JOUR

T1 - A Clostridium difficile-fertozések epidemiológiája, betegségterhe és terápiája

AU - Gulácsi, László

AU - Kertész, Adrienne

AU - Kopcsóné Németh, Irén

AU - Banai, János

AU - Ludwig, Endre

AU - Prinz, Gyula

AU - Reményi, Péter

AU - Strbák, Bálint

AU - Urbán, Edit Zsoldiné

AU - Baji, Petra

AU - Péntek, Márta

AU - Brodszky, Valentin

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Introduction:C. difficile causes 25 percent of the antibiotic associated infectious nosocomial diarrhoeas. C. difficile infection is a high-priority problem of public health in each country. The available literature of C. difficile infection's epidemiology and disease burden is limited. Aim: Review of the epidemiology, including seasonality and the risk of recurrences, of the disease burden and of the therapy of C. difficile infection. Method: Review of the international and Hungarian literature in MEDLINE database using PubMed up to and including 20th of March, 2012. Results: The incidence of nosocomial C. difficile associated diarrhoea is 4.1/10 000 patient day. The seasonality of C. difficile infection is unproved. 20 percent of the patients have recurrence after metronidazole or vancomycin treatment, and each recurrence increases the chance of a further one. The cost of C. difficile infection is between 130 and 500 thousand HUF (430 and 1665) in Hungary. Conclusions: The importance of C. difficile infection in public health and the associated disease burden are significant. The available data in Hungary are limited, further studies in epidemiology and health economics are required.

AB - Introduction:C. difficile causes 25 percent of the antibiotic associated infectious nosocomial diarrhoeas. C. difficile infection is a high-priority problem of public health in each country. The available literature of C. difficile infection's epidemiology and disease burden is limited. Aim: Review of the epidemiology, including seasonality and the risk of recurrences, of the disease burden and of the therapy of C. difficile infection. Method: Review of the international and Hungarian literature in MEDLINE database using PubMed up to and including 20th of March, 2012. Results: The incidence of nosocomial C. difficile associated diarrhoea is 4.1/10 000 patient day. The seasonality of C. difficile infection is unproved. 20 percent of the patients have recurrence after metronidazole or vancomycin treatment, and each recurrence increases the chance of a further one. The cost of C. difficile infection is between 130 and 500 thousand HUF (430 and 1665) in Hungary. Conclusions: The importance of C. difficile infection in public health and the associated disease burden are significant. The available data in Hungary are limited, further studies in epidemiology and health economics are required.

KW - C. difficile infection

KW - costs

KW - epidemiology

KW - Hungary

UR - http://www.scopus.com/inward/record.url?scp=84881047964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881047964&partnerID=8YFLogxK

U2 - 10.1556/OH.2013.29674

DO - 10.1556/OH.2013.29674

M3 - Article

C2 - 23876616

AN - SCOPUS:84881047964

VL - 154

SP - 1188

EP - 1193

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 30

ER -